Skip to main content
OpenTrials

Clinical trial condition

Microsatellite Stable Colorectal Cancer

Explore clinical trials studying Microsatellite Stable Colorectal Cancer. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Microsatellite Stable Colorectal Cancer trial results

Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details
Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

NCT06444815

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +56 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health Orange, California, United States
  • University of Miami Miami, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
View Trial Details
Completed

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT04332653

Conditions
Adnexal Diseases, Any Advanced Solid Tumors, Breast Diseases, +41 more
Locations
  • Moffit Cancer Center Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread

NCT02060188

Conditions
Microsatellite Stable Colorectal Cancer, Microsatellite Unstable Colorectal Cancer, Mismatch Repair Deficient Colorectal Cancer, +1 more
Locations
  • Local Institution - 0028 Gilbert, Arizona, United States
  • Local Institution - 0004 Los Angeles, California, United States
  • Local Institution - 0001 San Francisco, California, United States
  • Local Institution - 0008 Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Completed

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

NCT03473925

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Honor Health ( Site 0005) Scottsdale, Arizona, United States
  • Florida Cancer Specialists ( Site 0003) Sarasota, Florida, United States
  • University of Maryland ( Site 0008) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0006) Detroit, Michigan, United States
View all 14 locations
View Trial Details
Completed

Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer

NCT03658772

Conditions
Microsatellite Stable Colorectal Cancer
Locations
  • Mayo Clinic Cancer Center - Scottsdale Phoenix, Arizona, United States
  • University of Colorado Denver-Anschutz Medical Campus Aurora, Colorado, United States
  • Sarah Cannon Research Institute, LLC (SCRI) Nashville, Tennessee, United States
  • New Experimental Therapeutics of San Antonio-NEXT Oncology San Antonio, Texas, United States
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Dresden, Saxony, Germany
View Trial Details

Related conditions